Just a moment, the page is loading...

GSK-BRL-029060/377




A Double-blind, Multicentre Placebo-Controlled Study of Paroxetine in Adolescents with Unipolar Major Depression.
paroxetine
BRL-029060/377
Depressive Disorder, Major
Phase 3
An analysis-ready dataset is not available for this study. An annotated case report form is not available for this study. A blank case report form will be provided. A link to ClinicalTrials.gov and an NCTID number are not available for this study because the study is not in scope of regulatory requirements to register studies.
May 2014